This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,640,542
The ICONIC trial: Intraoperative Cell salvage to Optimize allogeNeic transfusion In liver Cancer surgery
CIHR · 2026 · Principal investigator
- $4,039,200
The TOPGUN trial: Threshold for OPerative hemoGlobin trigger for red blood cell transfUsioN
CIHR · 2026 · Co-investigator
- $642,868
DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery
CIHR · 2022 · Co-investigator
The ICONIC trial: Intraoperative Cell salvage to Optimize allogeNeic transfusion In liver Cancer surgery
Principal investigators: Martel, Guillaume; Karanicolas, Paul J; Taljaard, Monica
Keywords: Blood Salvage; Blood Transfusion; Cell Salvage; Cholangiocarcinoma; Colorectal Cancer; Hepatectomy; Hepatocellular Carcinoma; Liver Surgery; Patient Blood Management; Survival
The TOPGUN trial: Threshold for OPerative hemoGlobin trigger for red blood cell transfUsioN
Principal investigators: Martel, Guillaume; Breau, Rodney H; Carrier, François M; McGinn, Ryan N; McIsaac, Daniel I; Taljaard, Monica; Turgeon, Alexis F; Verret, Michael
Keywords: Anesthesiology; Blood Transfusion; Cancer Outcomes; Perioperative Care; Perioperative Complications; Surgery
DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery
Principal investigators: Martel, Guillaume; Fergusson, Dean A
Keywords: Hepatectomy; Hepatic Vein Embolization; Interventional Radiology; Liver; Metastatic Colorectal Cancer; Portal Vein Embolization; Randomized Controlled Trial; Regeneration; Resectability; Survival
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.